Cannara Biotech Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
181.0M
P/E Ratio
15.75
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
TSXV
Key Financial Metrics
107.2M
Revenue
13.1M
Net Income
C$0.14
EPS (Diluted)
13.7M
Free Cash Flow
Profitability
Gross Margin
43.9%
Operating Margin
20.3%
Net Profit Margin
12.2%
EBITDA
28.5M
Returns & Efficiency
Return on Assets (ROA)
7.8%
Return on Equity (ROE)
12.8%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
168.6M
Total Debt
41.6M
Debt to Equity
0.41x
Current Ratio
2.40
Company Info
| Industry | Drug Manufacturers - Specialty & Generic |
| HQ | Saint-Laurent, Canada |
| Employees | 452 |
| Fiscal Year End | 1756598400 |
| Currency | CAD |
| Website | cannara.ca |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
1,204,583
Shares Sold
0
Total Transactions
7
Interactive Charts
Company Profile
General Information
| Company Name | Cannara Biotech Inc. |
| Ticker | LOVE.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Headquarters | Saint-Laurent, Canada |
| Employees | 452 |
| Fiscal Year End | 1756598400 |
| Currency | CAD |
| Website | cannara.ca |
Financial Summary
| Market Cap | 181.0M |
| Revenue | 107.2M |
| Net Income | 13.1M |
| P/E Ratio | 15.75 |
| EPS (Diluted) | C$0.14 |
| Net Margin | 12.2% |
| ROE | 12.8% |
| Dividend Yield | N/A |
Business Description
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.